BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24820476)

  • 1. Effect of laser acupuncture on salivary flow rate in patients with Sjögren's syndrome.
    Cafaro A; Arduino PG; Gambino A; Romagnoli E; Broccoletti R
    Lasers Med Sci; 2015 Aug; 30(6):1805-9. PubMed ID: 24820476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects on local blood flux of acupuncture stimulation used to treat xerostomia in patients suffering from Sjögren's syndrome.
    Blom M; Lundeberg T; Dawidson I; Angmar-Månsson B
    J Oral Rehabil; 1993 Sep; 20(5):541-8. PubMed ID: 10412476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of acupuncture in the treatment of patients with primary Sjögren's syndrome. A controlled study.
    List T; Lundeberg T; Lundström I; Lindström F; Ravald N
    Acta Odontol Scand; 1998 Apr; 56(2):95-9. PubMed ID: 9669460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A scoping review on hyposalivation associated with systemic conditions: the role of physical stimulation in the treatment approaches.
    Melo JLMA; Coelho CPES; Nunes FPES; Heller D; Grisi DC; Guimarães MDCM; Dame-Teixeira N
    BMC Oral Health; 2023 Jul; 23(1):505. PubMed ID: 37480103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrical stimulation of salivary flow in patients with Sjögren's syndrome.
    Steller M; Chou L; Daniels TE
    J Dent Res; 1988 Oct; 67(10):1334-7. PubMed ID: 3262637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acupuncture for Primary Sjögren Syndrome (pSS) on symptomatic improvements: study protocol for a randomized controlled trial.
    Jiang Q; Zhang H; Pang R; Chen J; Liu Z; Zhou X
    BMC Complement Altern Med; 2017 Jan; 17(1):61. PubMed ID: 28103850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine concentrations in stimulated whole saliva among patients with primary Sjögren's syndrome, secondary Sjögren's syndrome, and patients with primary Sjögren's syndrome receiving varying doses of interferon for symptomatic treatment of the condition: a preliminary study.
    Streckfus C; Bigler L; Navazesh M; Al-Hashimi I
    Clin Oral Investig; 2001 Jun; 5(2):133-5. PubMed ID: 11480812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of salivary gland dysfunction in patients with Sjogren's syndrome.
    Pijpe J; Kalk WW; Bootsma H; Spijkervet FK; Kallenberg CG; Vissink A
    Ann Rheum Dis; 2007 Jan; 66(1):107-12. PubMed ID: 16728458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary gland dysfunction and xerostomia in Sjögren's syndrome.
    Jensen SB; Vissink A
    Oral Maxillofac Surg Clin North Am; 2014 Feb; 26(1):35-53. PubMed ID: 24287192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sialendoscopy enhances salivary gland function in Sjögren's syndrome: a 6-month follow-up, randomised and controlled, single blind study.
    Karagozoglu KH; Vissink A; Forouzanfar T; Brand HS; Maarse F; Jager DHJ
    Ann Rheum Dis; 2018 Jul; 77(7):1025-1031. PubMed ID: 29475854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between salivary epidermal growth factor levels and refractory intraoral manifestations in patients with Sjögren's syndrome.
    Azuma N; Katada Y; Kitano S; Sekiguchi M; Kitano M; Nishioka A; Hashimoto N; Matsui K; Iwasaki T; Sano H
    Mod Rheumatol; 2014 Jul; 24(4):626-32. PubMed ID: 24252043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of unstimulated flow rates of whole and palatal saliva in healthy patients wearing complete dentures and in patients with Sjogren's syndrome.
    Márton K; Boros I; Fejérdy P; Madléna M
    J Prosthet Dent; 2004 Jun; 91(6):577-81. PubMed ID: 15211301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elucidating the role of hyposalivation and autoimmunity in oral candidiasis.
    Billings M; Dye BA; Iafolla T; Grisius M; Alevizos I
    Oral Dis; 2017 Apr; 23(3):387-394. PubMed ID: 27998016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of salivary gland hypofunction in primary and secondary Sjögren's syndrome.
    Dawson LJ; Holt DJ; Higham SM; Longman LP; Field EA
    Oral Dis; 2001 Jan; 7(1):28-30. PubMed ID: 11354918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of a commercially available oral moisturizer in relieving signs and symptoms of xerostomia in postirradiation head and neck cancer patients and patients with Sjögren's syndrome.
    Rhodus NL; Bereuter J
    J Otolaryngol; 2000 Feb; 29(1):28-34. PubMed ID: 10709169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salivary gland function in Sjögren's syndrome: a review.
    Chisholm DM; Mason DK
    Br Dent J; 1973 Nov; 135(9):393-9. PubMed ID: 4607042
    [No Abstract]   [Full Text] [Related]  

  • 17. Progression of sialadenitis in Sjögren's syndrome.
    Jonsson R; Kroneld U; Bäckman K; Magnusson B; Tarkowski A
    Br J Rheumatol; 1993 Jul; 32(7):578-81. PubMed ID: 8339128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of a liquid diet on salivary flow in primary Sjögren's syndrome.
    Peen E; Haga HJ; Haugen AJ; Kahrs GE; Haugen M
    Scand J Rheumatol; 2008; 37(3):236-7. PubMed ID: 18465463
    [No Abstract]   [Full Text] [Related]  

  • 19. Intraoperative visualisation and treatment of salivary glands in Sjögren's syndrome by contrast-enhanced ultrasound sialendoscopy (CEUSS): protocol for a phase I single-centre, single-arm, exploratory study.
    Karagozoglu KH; Helder M; Bot J; Kamp O; Forouzanfar T; Brand HS; Cha S; Weisman G; Bartelink I; Vissink A; Jager DHJ
    BMJ Open; 2020 Sep; 10(9):e033542. PubMed ID: 32998913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sjögren's syndrome].
    Ernst D; Witte T
    Dtsch Med Wochenschr; 2016 Apr; 141(8):544-50. PubMed ID: 27078243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.